7-151876510-A-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_016203.4(PRKAG2):​c.111T>A​(p.Ile37Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00412 in 1,605,746 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. I37I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0025 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 17 hom. )

Consequence

PRKAG2
NM_016203.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:18

Conservation

PhyloP100: 0.350

Publications

2 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2-AS1 (HGNC:40468): (PRKAG2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 7-151876510-A-T is Benign according to our data. Variant chr7-151876510-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 45688.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00246 (374/151940) while in subpopulation NFE AF = 0.00406 (276/67942). AF 95% confidence interval is 0.00367. There are 1 homozygotes in GnomAd4. There are 184 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 374 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016203.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
NM_016203.4
MANE Select
c.111T>Ap.Ile37Ile
synonymous
Exon 1 of 16NP_057287.2
PRKAG2
NM_001407021.1
c.111T>Ap.Ile37Ile
synonymous
Exon 1 of 15NP_001393950.1
PRKAG2
NM_001407022.1
c.111T>Ap.Ile37Ile
synonymous
Exon 1 of 15NP_001393951.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
ENST00000287878.9
TSL:1 MANE Select
c.111T>Ap.Ile37Ile
synonymous
Exon 1 of 16ENSP00000287878.3Q9UGJ0-1
PRKAG2
ENST00000488258.5
TSL:1
n.111T>A
non_coding_transcript_exon
Exon 1 of 10ENSP00000420783.1F8WDA1
PRKAG2
ENST00000652321.2
c.111T>Ap.Ile37Ile
synonymous
Exon 1 of 16ENSP00000498886.2A0A494C155

Frequencies

GnomAD3 genomes
AF:
0.00248
AC:
376
AN:
151824
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00102
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00409
Gnomad OTH
AF:
0.00288
GnomAD2 exomes
AF:
0.00242
AC:
592
AN:
245054
AF XY:
0.00223
show subpopulations
Gnomad AFR exome
AF:
0.000680
Gnomad AMR exome
AF:
0.00298
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000371
Gnomad NFE exome
AF:
0.00397
Gnomad OTH exome
AF:
0.00361
GnomAD4 exome
AF:
0.00430
AC:
6247
AN:
1453806
Hom.:
17
Cov.:
31
AF XY:
0.00414
AC XY:
2996
AN XY:
723654
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33466
American (AMR)
AF:
0.00302
AC:
135
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86232
European-Finnish (FIN)
AF:
0.000261
AC:
12
AN:
45966
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5708
European-Non Finnish (NFE)
AF:
0.00522
AC:
5799
AN:
1111586
Other (OTH)
AF:
0.00453
AC:
273
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
289
577
866
1154
1443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00246
AC:
374
AN:
151940
Hom.:
1
Cov.:
32
AF XY:
0.00248
AC XY:
184
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41410
American (AMR)
AF:
0.00314
AC:
48
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5120
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00406
AC:
276
AN:
67942
Other (OTH)
AF:
0.00285
AC:
6
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00370
Hom.:
0
Bravo
AF:
0.00287
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00453
EpiControl
AF:
0.00421

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
4
not provided (4)
-
-
2
Cardiomyopathy (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Hypertrophic cardiomyopathy (1)
-
1
-
Hypertrophic cardiomyopathy 6 (1)
-
-
1
Lethal congenital glycogen storage disease of heart (1)
-
-
1
Wolff-Parkinson-White pattern (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
10
DANN
Benign
0.92
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144426409; hg19: chr7-151573595; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.